Related Experiment Videos

[Management of children with fatal liver diseases with reference to eventual liver transplantation]

W R Cario1, H Mau, H Giest

  • 1II. Kinderklinik des Klinikums Berlin-Buch.

Infusionstherapie (Basel, Switzerland)
|October 1, 1988
PubMed

Insights

Children with severe liver diseases like alpha 1-antitrypsin deficiency hepatopathies require monitoring for liver transplant. Key indicators of liver insufficiency include elevated indirect bilirubin and reduced cholinesterase activity. Prognosis prediction for these conditions remains challenging.

Area of Science:

  • Pediatric Hepatology
  • Biochemical Markers of Liver Function
  • Gastroenterology

Context:

  • Management of pediatric liver diseases including alpha 1-antitrypsin deficiency hepatopathies, autoimmune hepatitis, and extrahepatic biliary atresia.
  • Focus on optimizing care for potential liver transplantation in cases of liver insufficiency.
  • Importance of laboratory parameters in assessing hepatic insufficiency.

Purpose:

  • To highlight key laboratory indicators of liver insufficiency in children with severe hepatopathies.
  • To discuss the clinical significance of elevated indirect bilirubin, decreased cholinesterase activity, and the Quick test.
  • To address the current limitations in predicting the prognosis of severe pediatric hepatopathies based on longitudinal data.

Summary:

  • Children with severe hepatopathies undergo monitoring for liver transplant eligibility.
  • Elevated indirect bilirubin, decreased cholinesterase, and low Quick test results signal hepatic insufficiency.
  • Predicting prognosis in severe pediatric liver disease remains difficult despite longitudinal studies.

Impact:

  • Informs clinical practice regarding the monitoring of pediatric liver insufficiency.
  • Emphasizes the role of specific biochemical markers in patient assessment.
  • Identifies a gap in predictive capabilities for severe pediatric hepatopathies, guiding future research.

Related Concept Videos